Tislelizumab Combined with SOX and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Metastasis: a Prospective Cohort Study
Clinical trial NCT06682182 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06682182
- Sponsor
- Southwest Hospital, China
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-01
- Primary completion
- 2026-12-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.